Astera Labs, Inc. (NASDAQ:ALAB) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has been given a consensus recommendation of “Moderate Buy” by the twenty-three research firms that are covering the company, Marketbeat Ratings reports. Eleven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $233.75.

Several brokerages have issued reports on ALAB. Roth Mkm reaffirmed a “buy” rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price for the company. Needham & Company LLC lifted their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Citigroup downgraded Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday. Finally, Loop Capital began coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 2,316,257 shares of company stock valued at $474,860,636. 12.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Nordea Investment Management AB bought a new position in shares of Astera Labs in the fourth quarter worth $2,028,000. Geneva Partners LLC bought a new position in shares of Astera Labs in the third quarter worth $1,876,000. Numerai GP LLC increased its position in shares of Astera Labs by 153.1% in the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares during the period. Swedbank AB increased its position in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. Finally, Handelsbanken Fonder AB increased its position in shares of Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after purchasing an additional 93,800 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $343.05 on Friday. The business has a fifty day simple moving average of $190.82 and a two-hundred day simple moving average of $165.12. Astera Labs has a 1 year low of $84.78 and a 1 year high of $354.53. The company has a market capitalization of $58.80 billion, a price-to-earnings ratio of 231.79, a P/E/G ratio of 4.62 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter last year, the firm posted $0.33 EPS. The company’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts anticipate that Astera Labs will post 1.84 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.